Burden of deep vein thrombosis in the outpatient setting following major orthopedic surgery

被引:25
作者
Nutescu, Edith A. [2 ]
Shorr, Andrew F. [3 ,4 ]
Farrelly, Eileen [1 ]
Horblyuk, Ruslan [5 ]
Happe, Laura E. [1 ]
Franklin, Meg [1 ]
机构
[1] Xcenda, Palm Harbor, FL 34685 USA
[2] Univ Illinois, Coll Pharm, Dept Pharm Practice, Chicago, IL USA
[3] Washington Hosp Ctr, Washington, DC 20010 USA
[4] Georgetown Univ, Washington, DC USA
[5] GlaxoSmithKline, Philadelphia, PA USA
关键词
costs; deep vein thrombosis; fondaparinux; low-molecular-weight heparin; orthopedic surgery; outpatient prophylaxis; pulmonary embolism; warfarin;
D O I
10.1345/aph.1L135
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
BACKGROUND: Venous thromboembolism (VTE) is a known complication of major orthopedic surgery (MOS) with important clinical and economic consequences. Recently published orthopedic guidelines have focused on prevention of pulmonary embolism as a primary outcome, but deep vein thrombosis (DVT) occurrence should not be readily dismissed. OBJECTIVE: To describe the burden of DVT following hospital discharge for MOS by assessing the impact of DVT on costs and resource utilization from the third-party payer perspective. METHODS: Retrospective analysis used outpatient medical and pharmacy data from the PharMetrics Patient-Centric Database (January 1, 2002-March 31, 2006). Patients 18 years of age or older with a record of MOS were eligible for inclusion. Included patients were stratified based on the presence of a DVT during the first month after hospital discharge. Characteristics of the samples were described. The impact of DVT on total 6-month costs and resource utilization (readmissions, outpatient, emergency department visits) was assessed through statistical models. RESULTS: Of the 32,899 patients in the analysis, 1221 (3.71%) had a record of DVT during the first month following discharge for MOS. Compared with patients who did not develop DVT, patients who developed DVT postdischarge were slightly older (56.5 vs 55.8 y; p = 0.0127), had a higher occurrence of prior VTE (26.2% vs 3.4%; p < 0.0001), and had undergone recent surgical procedures other than MOS (73.0% vs 69.6%; p = 0.0116). After controlling for potential confounders, DVT was associated with a 22% and 740/6 increase in the average number of expected outpatient and emergency department visits, respectively, during the 6-month postdischarge period but did not significantly impact the number of readmissions. Furthermore, total 6-month costs were significantly higher for patients who developed DVT, with an incremental increase of over $2000. CONCLUSIONS: The burden of DVT following hospital discharge for MOS is substantial. Specifically, DVT increases total costs and outpatient and emergency department visits.
引用
收藏
页码:1216 / 1221
页数:6
相关论文
共 15 条
[1]
American Academy of Orthopedic Surgeons (US), 2007, AM AC ORTH SURG CLIN, P63
[2]
A meta-analysis of thromboembolic prophylaxis in total knee arthroplasty [J].
Brookenthal, KR ;
Freedman, KB ;
Lotke, PA ;
Fitzgerald, RH ;
Lonner, JH .
JOURNAL OF ARTHROPLASTY, 2001, 16 (03) :293-300
[3]
Economic burden of long-term complications of deep vein thrombosis after total hip replacement surgery in the United States [J].
Caprini, JA ;
Botteman, MF ;
Stephens, JM ;
Nadipelli, V ;
Ewing, MM ;
Brandt, S ;
Pashos, CL ;
Cohen, AT .
VALUE IN HEALTH, 2003, 6 (01) :59-74
[4]
Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement -: A meta-analysis of prospective studies investigating symptomatic outcomes [J].
Douketis, JD ;
Eikelboom, JW ;
Quinlan, DJ ;
Willan, AR ;
Crowther, MA .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (13) :1465-1471
[5]
Prevention of deep-vein thrombosis after total hip arthroplasty - Comparison of warfarin and dalteparin [J].
Francis, CW ;
Pellegrini, VD ;
Totterman, S ;
Boyd, AD ;
Marder, VJ ;
Liebert, KM ;
Stulberg, BN ;
Ayers, DC ;
Rosenberg, A ;
Kessler, C ;
Johanson, NA .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1997, 79A (09) :1365-1372
[6]
Prevention of venous thromboembolism [J].
Geerts, WH ;
Pineo, GF ;
Heit, JA ;
Bergqvist, D ;
Lassen, MR ;
Colwell, CW ;
Ray, JG .
CHEST, 2004, 126 (03) :338S-400S
[7]
Postthrombotic syndrome after hip or knee arthroplasty - A cross-sectional study [J].
Ginsberg, JS ;
Gent, M ;
Turkstra, F ;
Buller, HR ;
MacKinnon, B ;
Magier, D ;
Hirsh, J .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (05) :669-672
[8]
Howard AW, 1998, THROMB HAEMOSTASIS, V79, P902
[9]
Effect of postthrombotic syndrome on health-related quality of life after deep venous thrombosis [J].
Kahn, SR ;
Hirsch, A ;
Shrier, I .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (10) :1144-1148
[10]
Economic consequences of venous thromboembolism following major orthopedic surgery [J].
Oster, G ;
Ollendorf, DA ;
Vera-Llonch, M ;
Hagiwara, M ;
Berger, A ;
Edelsberg, J .
ANNALS OF PHARMACOTHERAPY, 2004, 38 (03) :377-382